Sarcoidosis: Benefits of a multidisciplinary approach

European Journal of Internal Medicine

Volumn 14, Issue 4, 2003, Pages 217-220

  Drent, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Multidisciplinary approach; Patient care; Sarcoidosis; Symptoms

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTHRALGIA; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EYE DISEASE; HUMAN; HYPERCALCEMIA; INFLAMMATION; LABORATORY TEST; LUNG BIOPSY; LUNG DISEASE; LUNG LAVAGE; MEDICAL RESEARCH; MEDICAL SPECIALIST; PATIENT CARE; PULMONOLOGY; REMISSION; REVIEW; SARCOIDOSIS; SKIN DEFECT; SOCIAL PSYCHOLOGY; SYMPTOM; SYSTEMIC DISEASE; TRANSPLANTATION;

EID: 0042206453     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(03)00076-1     Document Type: Review

References (26)

1. Hunninghake G.W., Costabel U., Ando M., et al. Statement on Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 16:1999;149-173.
2. McGrath D.S., Goh N., Foley P.J., du Bois R.M. Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis. 18:2001;149-164.
3. James D.G. Complications of sarcoidosis. Chronic fatigue syndrome. Sarcoidosis. 10:1993;1-3.
4. Wirnsberger R.M., De Vries J., Wouters E.F.M., Drent M. Clinical presentation of sarcoidosis in the Netherlands. An epidemiological study. Neth J Med. 53:1998;53-60.
5. DeRemee R.D. Dysphoria and sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 15:1998;21.
6. Drent M., Wirnsberger R.M., De Vries J., et al. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J. 13:1999;718-722.
7. Sharma O.P. Fatigue and sarcoidosis. Eur Respir J. 13:1999;713-714.
8. Drent M., Verbraecken J.A.S., Grinten van Ch., Wouters E.F.M. Fatigue associated with obstructive sleep apnea in a patient with sarcoidosis. Respiration. 67:2000;337-340.
9. Hoitsma E., De Vries J., van Santen-Hoefft M., Faber C.G., Drent M. Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis. 20:2003;33-39.
10. Wirnsberger R.M., Drent M., Hekelaar N., et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J. 10:1997;1450-1455.
11. Drent M., Wirnsberger R.M., Breteler M.H.M., et al. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 15:1998;59-66.
12. Wirnsberger R.M., De Vries J., Breteler M.H.M., et al. Evaluation of quality of life in sarcoidosis patients. Respir Med. 92:1998;550-556.
13. De Vries J., Drent M., Heck van G.L., Wouters E.F.M. Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample. Sarcoidosis Vasc Diffuse Lung Dis. 15:1998;183-188.
14. Drent M., Jacobs J.A., Cobben N.A.M., et al. Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release. Respir Med. 95:2001;781-786.
15. Baughman R.P. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med. 8:2002;464-469.
16. Paramothayan S., Jones P.W. Corticosteroid therapy in pulmonary sarcoidosis. J. Am. Med. Assoc. 287:2002;1301-1307.
17. Pietinalho A., Tukiainen P., Haahtela T., Persson T., Selroos O. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest. 121:2002;24.
18. Baughman R.P., Lower E.E. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 18:2001;70-74.
19. Baughman R.P., Judson M.A., Teirstein A.S., Moller D.R., Lower E.E. Thalidomide for chronic sarcoidosis. Chest. 122:2002;227-232.
20. Drent M., Berg van den R., Haenen G.R.M.M., et al. NF-κB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 18:2001;50-56.
21. Rothkrantz-Kos S., Drent M., Vuil H., et al. Decreased redox state in red blood cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 19:2002;114-120.
22. Drent M., Jacobs J.A., De Vries J., et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J. 13:1999;1338-1344.
23. Ziegenhagen M.W., Rothe M., Schlaak M., Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J. 21:2003;407-413.
24. Drent M., Bomans P.H.H., Suylen van R.J. Association of man-made mineral fibre exposure and sarcoid like granulomas. Respir Med. 94:2000;815-820.
25. Hoitsma E., Marziniak M., Faber C.G. Small fiber neuropathy in sarcoidosis. Lancet. 359:2002;2085-2086.
26. Verleden G.M., Du Bois R.M., Bouros D., et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J. 18:(Suppl. 32):2001;17s-29s.